is semaglutide dosage based on weight Wegovy Dosing: What Loss Semaglutide for Weight Loss: What

- ltere Patienten ab 65 Jahren: Das Arzneimittel sollte in der Regel in dieser Altersgruppe nicht angewendet werden

Once bound, those compounds are carried out of the body through bowel movements rather than being reabsorbed

Patients with a body mass index BMI of 30 or more, or a BMI of 27 with related conditions, will receive 2.4 mg injections once per week

Feeling hot or warm: A sensation of internal warmth, particularly in the chest and core Feeling warmer than usual in the hours after injection Running warmer at night noticeably different from pre-treatment baseline Mild sweating without exertion or elevated ambient temperature Flushing: Brief episodes of facial or chest flushing Warmth that comes in waves rather than continuously Redness that resolves within minutes to hours Feeling cold (less commonly): A smaller subset of patients report the opposite feeling colder than usual Most plausible explanation: as the acute thermogenic effect subsides in the days between injections, and as substantial fat loss removes insulating tissue, some patients experience a new cold sensitivity that wasn't present before treatment What we don't know precisely: The exact percentage of retatrutide patients who experience thermal sensations this was not a reported endpoint in TRIUMPH-4 or TRIUMPH-1 Whether the effect is more pronounced at 12mg vs 9mg (though glucagon pharmacology predicts dose-dependence) How quickly it typically resolves after each injection patient reports vary What the mechanistic evidence does support clearly: glucagon receptor activation raises metabolic rate and activates brown adipose tissue thermogenesis

Safety Profile: Observed effects are consistent with the incretin class, including manageable gastrointestinal transitions such as nausea or mild digestive changes